Stay updated on Palbociclib With Standard Treatment in Residual Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Palbociclib With Standard Treatment in Residual Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Palbociclib With Standard Treatment in Residual Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the lapse-in-government-funding notice and Revision: v3.4.1 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:37:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH Clinical Center operations was added. The page revision tag was updated to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T04:20:40.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI and labeling updates include showing a glossary option, updating the 'Last Update Submitted that Met QC Criteria' label and adding 'No FEAR Act Data' and 'Revision: v3.4.0'. The prior labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:52:41.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page's revision history shows the addition of Revision: v3.3.4 and removal of Revision: v3.3.3, a minor backend update with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:35:22.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new Locations section is added, listing Pennsylvania and NSW 2310 sites. The old separate location blocks and the HHS Vulnerability Disclosure link were removed, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T09:42:51.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2; no substantive changes to trial content or eligibility criteria were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:49:18.000Z thumbnail image

Stay in the know with updates to Palbociclib With Standard Treatment in Residual Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Palbociclib With Standard Treatment in Residual Breast Cancer Clinical Trial page.